Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management.

Doan, David K; Schmidt, Keith T; Chau, Cindy H; Figg, William D

Doan, David K; Schmidt, Keith T; Chau, Cindy H; Figg, William D.

Afiliação

Doan DK; Emory University Hospital, Atlanta, GA 30322, USA.
Schmidt KT; Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Chau CH; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Figg WD; Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

Cancers (Basel) ; 13(9)2021 Apr 29.

Article em En | MEDLINE | ID: mdl-33947030

Palavras-chave

genetics; germline testing; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google